Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P276-00 in Advanced Head and Neck Cancer
NCT00824343Phase 2Completed
- Sponsor
- Piramal Enterprises Limited
- Start
- Sep 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of P276 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Piramal Enterprises Limited. Primary endpoint: Response Rate. Started Sep 2008; status: completed.
02
Drugs
P276
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00824343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824343.